• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Influence of Age on Behcet's Disease Activity.年龄对白塞病活动度的影响。
Eurasian J Med. 2008 Aug;40(2):68-71.
2
Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters.白塞病患者血清生长分化因子15水平:疾病活动度与临床参数之间的关系
Int J Dermatol. 2016 Nov;55(11):1289-1294. doi: 10.1111/ijd.13309.
3
Impact of disease activity on health related quality of life in patients with Behçet's disease: A cross-sectional study.白塞病患者疾病活动度对健康相关生活质量的影响:一项横断面研究。
Ann Med Surg (Lond). 2020 Apr 13;54:43-46. doi: 10.1016/j.amsu.2020.03.010. eCollection 2020 Jun.
4
Is there a relation between clinical disease activity and acute phase response in Behcet's disease?白塞病的临床疾病活动与急性期反应之间存在关联吗?
Int J Dermatol. 2014 Feb;53(2):250-4. doi: 10.1111/ijd.12224. Epub 2013 Nov 21.
5
Development of an Arabic version of the Behçet's Disease Current Activity Form (Ar-BDCAF): cross-cultural adaptation and validation initiative in Egypt.《贝切特病活动评估表(Ar-BDCAF)阿拉伯语版本的研制:埃及的跨文化调适和验证研究》
Clin Rheumatol. 2021 Nov;40(11):4609-4618. doi: 10.1007/s10067-021-05817-1. Epub 2021 Jun 25.
6
Serum anti-lysozyme is associated with disease activity of Behçet's disease.血清抗溶菌酶与白塞病的疾病活动相关。
Int J Rheum Dis. 2017 Feb;20(2):261-268. doi: 10.1111/1756-185X.12832. Epub 2016 Feb 18.
7
An evaluation of depression, anxiety and fatigue in patients with Behçet's disease.评估白塞病患者的抑郁、焦虑和疲劳情况。
Int J Rheum Dis. 2019 Jun;22(6):974-979. doi: 10.1111/1756-185X.13411. Epub 2018 Nov 5.
8
The performance of different classification criteria in paediatric Behçet's disease.不同分类标准在儿童贝赫切特病中的表现。
Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):119-123. Epub 2017 Apr 5.
9
Increased advanced oxidation protein products in Behçet's disease: a new activity marker?白塞病中晚期氧化蛋白产物增加:一种新的活性标志物?
Br J Dermatol. 2004 Jul;151(1):105-11. doi: 10.1111/j.1365-2133.2004.06003.x.
10
Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet's disease.血清钙卫蛋白和缺血修饰白蛋白水平作为白塞病疾病活动度的标志物
Postepy Dermatol Alergol. 2018 Dec;35(6):609-613. doi: 10.5114/pdia.2017.71269. Epub 2018 Nov 13.

引用本文的文献

1
Functional and taxonomic dysbiosis of the supragingival plaque metagenome in Behçet's disease.白塞病龈上菌斑宏基因组的功能和分类失调
J Oral Microbiol. 2025 Aug 29;17(1):2552165. doi: 10.1080/20002297.2025.2552165. eCollection 2025.
2
Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study.神经白塞病采用英夫利昔单抗治疗的长期预后:单中心回顾性研究。
Clin Rheumatol. 2024 Oct;43(10):3213-3221. doi: 10.1007/s10067-024-07118-9. Epub 2024 Aug 25.
3
Unfolding dermatologic spectrum of Behçet's disease in Italy: real-life data from the International AIDA Network Behçet's disease Registry.意大利贝切特病的皮肤病学表现:国际 AIDA 网络贝切特病注册研究的真实数据。
Intern Emerg Med. 2023 Nov;18(8):2245-2252. doi: 10.1007/s11739-023-03410-9. Epub 2023 Oct 6.
4
Clinical Manifestations of Behçet's Disease: A Retrospective Cross-Sectional Study.白塞病的临床表现:一项回顾性横断面研究。
Mediterr J Rheumatol. 2023 Mar 31;34(1):53-60. doi: 10.31138/mjr.34.1.53. eCollection 2023 Mar.
5
Vitamin D in Behcet's Disease, a Brief Review of the Literature.白塞病中的维生素D:文献综述
Eurasian J Med. 2022 Dec;54(Suppl1):29-33. doi: 10.5152/eurasianjmed.2022.22300.
6
Genital ulcer severity score and genital health quality of life in Behçet's disease.白塞病患者的生殖器溃疡严重程度评分与生殖器健康生活质量
Orphanet J Rare Dis. 2015 Sep 22;10:117. doi: 10.1186/s13023-015-0341-7.
7
Antistreptolysin O Levels in Patients with Behcet's Disease.白塞病患者的抗链球菌溶血素O水平
Eurasian J Med. 2011 Dec;43(3):169-72. doi: 10.5152/eajm.2011.33.

本文引用的文献

1
Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.迟发性白塞病与病情进展缓慢无关:7例台湾患者报告
J Eur Acad Dermatol Venereol. 2008 May;22(5):596-600. doi: 10.1111/j.1468-3083.2007.02556.x. Epub 2008 Feb 4.
2
Demographic and clinical properties of juvenile-onset Behçet's disease: A controlled multicenter study.青少年型白塞病的人口统计学和临床特征:一项对照多中心研究。
J Am Acad Dermatol. 2008 Apr;58(4):579-84. doi: 10.1016/j.jaad.2007.10.452. Epub 2007 Nov 28.
3
Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients.突尼斯的白塞病。260例患者的人口统计学、临床和遗传学特征
Clin Exp Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S58-64.
4
Clinical features and natural course of Behçet's disease in 661 cases: a multicentre study.661例白塞病的临床特征与自然病程:一项多中心研究
Br J Dermatol. 2007 Nov;157(5):901-6. doi: 10.1111/j.1365-2133.2007.08116.x. Epub 2007 Aug 17.
5
Arthropathy, quality of life, depression, and anxiety in Behcet's disease: relationship between arthritis and these factors.白塞病中的关节病、生活质量、抑郁和焦虑:关节炎与这些因素之间的关系。
Clin Rheumatol. 2006 Jul;25(4):524-31. doi: 10.1007/s10067-005-0100-6. Epub 2006 Apr 26.
6
Quality of life and life satisfaction in patients with Behçet's disease: relationship with disease activity.白塞病患者的生活质量与生活满意度:与疾病活动度的关系
Clin Rheumatol. 2006 May;25(3):329-33. doi: 10.1007/s10067-005-0046-8. Epub 2005 Nov 3.
7
Current concepts in the etiology and treatment of Behçet disease.白塞病的病因及治疗的当前概念
Surv Ophthalmol. 2005 Jul-Aug;50(4):297-350. doi: 10.1016/j.survophthal.2005.04.009.
8
Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease.对2313名土耳其贝赫切特病患者的临床症状按性别进行评估。
Int J Dermatol. 2003 May;42(5):346-51. doi: 10.1046/j.1365-4362.2003.01741.x.
9
Current therapy for Behçet's disease.白塞病的当前治疗方法。
Am J Ther. 2002 Sep-Oct;9(5):465-70. doi: 10.1097/00045391-200209000-00015.
10
Evaluation of the Turkish translation of a disease activity form for Behçet's syndrome.白塞氏综合征疾病活动表土耳其语翻译的评估
Rheumatology (Oxford). 1999 Aug;38(8):734-6. doi: 10.1093/rheumatology/38.8.734.

年龄对白塞病活动度的影响。

The Influence of Age on Behcet's Disease Activity.

作者信息

Melikoğlu Meltem Alkan, Melikoğlu Mehmet

机构信息

Atatürk University, School of Medicine, Physical Medicine and Rehabilitation, Erzurum, Turkey.

Atatürk University, School of Medicine, Dermatology, Erzurum, Turkey.

出版信息

Eurasian J Med. 2008 Aug;40(2):68-71.

PMID:25610030
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4261679/
Abstract

OBJECTIVE

Behcet's disease (BD) is a multi-systemic vasculitis characterized by a relapsing and remitting, rather than a persisting, disease course. It is thought that BD activity decreases as the age of the afflicted individual increases. Furthermore, disease severity is reported to be greater in individuals that first present with the disease at a young age. This study investigates the association between disease activity scores and both the current ages of BD patients and patient age at disease onset.

MATERIALS AND METHODS

Fifty patients with BD participated in this study. The gender, age, and age at disease onset of each patient was recorded. A BD Current Activity Form (BDCAF) was used to assign a clinical disease activity score for all enrolled patients. The participants were divided into subgroups according to 1) their current ages and 2) their ages at the onset of BD disease. In addition to BDCAF scores, erythrocyte sedimentation rates (ESR) and C-reactive protein (CRP) levels were compared across groups. Statistical analyses were performed using one-way ANOVA.

RESULTS

The mean patient age and the mean patient age at the time of disease onset were 34.68±9.71 and 26.10±7.07 years, respectively. Patients that were younger than 30 years of age exhibited significantly higher rates of oral ulceration and arthralgia, and had higher total BDCAF scores than patients that were older than 40 years of age (p=0.038, p=0.020, and p=0.026, respectively). Patients who developed BD before their twentieth year showed significantly higher total disease activity scores than patients in the oldest age at disease onset group (p < 0.05). No significant difference was observed in ESR and CRP levels between groups.

CONCLUSION

Our results demonstrate that younger BD patients and patients that first present with disease symptoms at a younger age have higher disease activity scores. Our results reinforce the importance of considering the age at disease onset when clinically treating individuals with BD.

摘要

目的

白塞病(BD)是一种多系统血管炎,其病程特点为复发缓解型,而非持续型。一般认为,随着患病个体年龄增长,白塞病的活动度会降低。此外,据报道,发病时年龄较小的个体疾病严重程度更高。本研究旨在调查疾病活动评分与白塞病患者当前年龄及发病年龄之间的关联。

材料与方法

50例白塞病患者参与了本研究。记录了每位患者的性别、年龄及发病年龄。使用白塞病当前活动表(BDCAF)为所有入组患者评定临床疾病活动评分。参与者根据1)当前年龄和2)白塞病发病年龄被分为亚组。除BDCAF评分外,还比较了各组的红细胞沉降率(ESR)和C反应蛋白(CRP)水平。采用单因素方差分析进行统计分析。

结果

患者的平均年龄及发病时的平均年龄分别为34.68±9.71岁和26.10±7.07岁。年龄小于30岁的患者口腔溃疡和关节痛发生率显著更高,且总BDCAF评分高于年龄大于40岁的患者(分别为p = 0.038、p = 0.020和p = 0.026)。20岁前发病的患者总疾病活动评分显著高于发病年龄最大组的患者(p < 0.05)。各组间ESR和CRP水平未观察到显著差异。

结论

我们的结果表明,较年轻的白塞病患者以及发病时年龄较小的患者疾病活动评分更高。我们的结果强化了临床治疗白塞病患者时考虑发病年龄的重要性。